Professor Andrew Holden (Auckland, New Zealand) is really excited about the 18 podium first presentations showcasing new data at CX 2023 and uniquely, the interaction between a world-class faculty and expert audience.
Register now to attend CX 2023! Take a look at the upcoming podium first highlights below.
|CX 2023 – PODIUM FIRST:Podium First: Primary endpoint results of the STRIDE trial on thrombectomy for acute limb ischemia
Bioresorbable Drug-Coated Stents Session
“We’ve got a dedicated session on bioabsorbable scaffolds – that’s been the holy grail for scaffolds for a number of years. In other words, we get the acute support of a scaffold or stent, but we don’t get the long-term problems with it.”
|Podium First: Statin treatment after aortic repair saves lives, but dose doesn’t matter
|Podium First: IN.PACT AV Access trial – 3 year subanalysis data
“I’ve been privileged to present data over the years at Charing Cross of the most powerful randomised control trial of drug coated balloons and AV access – the IN.PACT AV trial published in the New England Journal of Medicine.”
Podium First: A new kind of graft